Advisory Board member, Allen Edel authors an exceptional blog, Prostate Cancer News, Reviews & Views on various ‘technical’ prostate cancer matters – that’s just one of the reasons we are proud to have him on our Advisory Board. You’ll find the blog here where you can sign up for new posts … as of course you can with AnCan just to the right!
Allen’s latest post is an excellent treatise on PSMA, based on reviewing several studies. He makes a number of interesting points to bear in mind when considering PSMA based protocols, amongst them:
- consider getting both a PSMA and FDG basedPET/ CT scan before opting for radionuclide treatment
- PSMA is very heterogeneous i.e. it can be expressed differently certainly within the same man and maybe even amongst cells in the same tumor
- PARP-I’s can promote the potency of PSMA based treatments
Once again, AnCan expresses deep gratitude to Allen for keeping us well informed on important aspects of treatment that many medical practitioners, never mind advocates and patients, would otherwise miss.